SEC Form 4 · accession 0001209191-17-026788
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikin Patel
Officer — Chief Operating Officer · Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 13, 2017 · 6:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.05 | Apr 11, 2017 | A | 10,000 | A | — | Apr 11, 2024 | Common Stock, $0.01 par value per share | 10,000 | 10,000 | D |
Explanation of responses
- F1The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.